GGA2 activators encompass a diverse array of chemical compounds that indirectly influence the functional activity of GGA2 by modulating various signaling pathways and cellular processes associated with vesicle trafficking. Forskolin, for instance, by increasing intracellular cAMP, indirectly promotes GGA2's function in vesicle formation and trafficking through PKA activation and subsequent protein phosphorylation. The activation of PKC by Phorbol 12-myristate 13-acetate (PMA) could enhance GGA2's role in sorting cargo proteins by increasing the phosphorylation of proteins in the transport pathway. The role of GGA2 in vesicular transport is also potentially influenced by Ionomycin, which raises intracellular calcium levels, thus activating calcium-dependent kinases that could modify the activity of GGA2. Epigallocatechin gallate (EGCG) and Bisindolylmaleimide I, through their inhibitory effects on kinases, and Sphingosine-1-phosphate, through bioactive lipid signaling, may createan environment that favors GGA2's function in sorting mannose-6-phosphate receptors and enhances its activity in the trans-Golgi network. Similarly, the PI3K inhibitors LY294002 and Wortmannin may indirectly promote GGA2 activity by impacting membrane trafficking dynamics, which is integral to GGA2's role.
Moreover, the tyrosine kinase inhibitor NMPP1 can potentially enhance GGA2's efficiency by reducing competitive phosphorylation events within the vesicle trafficking pathway. The activity of GGA2 is further implicated to be influenced by the action of phosphatase inhibitors such as Okadaic acid and Calyculin A, which by maintaining higher phosphorylation levels of pathway proteins could indirectly augment GGA2-mediated sorting. Lastly, Go 6983, a broad-spectrum PKC inhibitor, may alter the phosphorylation state of proteins within the vesicular sorting processes, thus potentially facilitating the enhancement of GGA2's function. Collectively, these activators, through their targeted effects on cellular signaling and phosphorylation states, provide a biochemical landscape conducive to the enhanced activation of GGA2 without necessitating upregulation of its expression or direct activation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate target proteins, potentially enhancing the vesicle formation and trafficking functions of GGA2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could phosphorylate proteins within the vesicular trafficking pathway, potentially upregulating GGA2's role in the sorting of cargo proteins to the trans-Golgi network. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent kinases and phosphatases that modulate GGA2 function in vesicular transport. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound is a specific PKC inhibitor that could alter the phosphorylation state of proteins involved in the transport to the trans-Golgi network, indirectly enhancing GGA2-mediated sorting by modulating competitive phosphorylation events. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a bioactive lipid that can activate sphingosine-1-phosphate receptors, which could enhance GGA2 function indirectly by modulating endosomal sorting complexes required for transport (ESCRT) machinery. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, which could have a similar effect to LY294002, influencing GGA2 function in vesicular transport by altering the membrane dynamics. | ||||||
PP1 Analog II, 1NM-PP1 | 221244-14-0 | sc-203214 sc-203214A | 1 mg 5 mg | $106.00 $530.00 | 10 | |
NMPP1 is a tyrosine kinase inhibitor that could reduce competitive phosphorylation of proteins within the vesicle trafficking pathway, potentially allowing GGA2 to function more effectively in its role. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, which may enhance phosphorylation levels of proteins within GGA2's functional pathways, indirectly enhancing its activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, calyculin A inhibits phosphatases, potentially leading to an increased phosphorylation state that could enhance GGA2's role in trafficking. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go 6983 is a broad-spectrum PKC inhibitor; by modulating PKC activity, it may influence the phosphorylation state of proteins involved with GGA2's function in vesicular sorting and trafficking. | ||||||